You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康哲藥業(00867.HK)攜手劍橋大學及阿斯利康投資英國生物技術和生命科學領域
格隆匯 12-05 18:09

格隆匯12月5日丨康哲藥業(00867.HK)宣佈,集團通過其全資附屬公司與劍橋大學(通過劍橋大學賈奇商學院("賈奇商學院")行事)、AstraZeneca UK Limited("阿斯利康")於2019年12月5日簽訂了合作協議。通過合作,公司將在阿斯利康和賈奇商學院已建立的網絡和關係的支持下,在未來五年對英國生物技術和生命科學領域進行投資。

公司的投資將給公司在未來提供獲得被投資公司所研發產品在大中華地區(包括中國大陸、香港特別行政區、澳門特別行政區和台灣)權利的機會。

自2015年以來,阿斯利康一直在指導生物技術和生命科學研究人員及創新者方面發揮作用,並與賈奇商學院就各種計劃進行了合作,以促進企業發展並支持生命科學研究人員和學生的創業精神。

通過合作協議,公司、阿斯利康和賈奇商學院彰顯了加強生物技術和生命科學領域機會管道的共同目標,特別是在治療學、診斷學、設備和數字健康領域,從而為被投資公司提供更多進入國際市場(特別是大中華地區)的機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account